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Abstract
Background: Among the challenges encountered during the care of patients at the end-of-life (EOL), eliciting
preferences of patients with whom there is no ability to communicate is common and stressful for all those
concerned and charged with patient care. Legal facilities available include patient delegation of proxy decision-makers
(PDM) prior to communication incapacity. We sought to estimate family physician awareness and attitude with regard
to these aspects of patient care.
Methods: A telephone survey of family physicians in the Jerusalem, Israel, district using a standard questionnaire.
Results: 74 family physicians responded to the survey. The response rate was 42 % and the cooperation rate was 66 %.
Most of the respondents, (64 %), reported knowing that the PDM delegation facility exists, though only 24 % claimed
to have suggested to their patients that they consider this option. Approximately three-quarters, (78 %), treat
patients with whom they discussed other aspects of severe disease, disability or EOL. None of the physicians
working predominantly with religiously observant groups reported suggesting PDM delegation.
Conclusions: There is an apparent gap between family physician knowledge and their performance to empower
the persistence of patient autonomy, should communication ability cease. System-wide interventions to increase
EOL communication skills, starting at medical school and henceforth, are necessary in order to promote better
EOL care and meaningful resource use.
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Background
During the latter part of the 20th century, the concept
of patient autonomy surfaced, evolved and diffused to
all aspects of healthcare. Associated challenges include
circumstances in which patients are unable to commu-
nicate and actively divulge their thoughts, preferences
and wishes; nor can healthcare providers elicit them.
The tools available in these circumstances include
knowledge of the patient preferences and end-of-life
(EOL) instructions prior to communication incapacity
through validated documentation (paper, film or other
media). However, applying these instructions can be
challenging and the interpreters’ ethical and cultural
standpoints affect decision-making. Legal facilities exist
to designate court-appointed proxy decision-makers. In
these circumstances, the proxy decision- makers (PDM)
might not know what the patient would have wanted
and which ideals and preferences should guide them.
A third, middle road possibility, is that the patients, when
they have communication capacity, designate a PDM, either
with or without power of attorney, identifying the people
they entrust with the responsibility to fulfil their autonomy
if communication capabilities diminish. This option allows
patients to discuss their preferences and morals with their
designated PDM. In cases of diminished communication
capacity, The PDM would have already been introduced to
the critical issues, know of any explicit preferences and have
the flexibility and spirit to manage various clinical scenarios
that arise. The healthcare staff can assist the PDM in these
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deliberations, knowing that they are doing their best to
fulfill the patient’s autonomy.
Many patients might prefer to discuss these matters
during their better health periods in the clinic rather than
during illness [1]. Family/primary-care physicians seem to
be suitable to assist patients with EOL instructions and
designation of a PDM because they are sensitive and close
to the patients in their cultural and genealogical surround-
ings. They are also able to revisit these topics over time,
and allow maturation of the issues and dilemmas. Phys-
ician initiative is important and the troubling parts of the
discussion seem not to discourage patients, but rather
more, the physicians [2]. Patients who are in better con-
tact with their primary-care physicians have been shown
to be more aware of PDM designation possibilities [3].
The SUPPORT project (Study to Understand Prognoses
and Preferences for Outcomes and Risks of Treatments)
promoted communication focused on understanding pa-
tient beliefs and preferences regarding various medical
procedures, prior to their need [4]. Yet most of the evi-
dence on patient EOL instructions and PDM designation
comes from acute care settings and patients who are ill,
rather than stable and relatively healthy [5].
We sought to assess the willingness of primary-care
family physicians to assist patients and promote designa-
tion of a PDM and sought to identify perceived obstacles
in order to establish a framework for interventions and
improvement.
Methods
A cross-sectional telephone survey of family physicians
using a standardized questionnaire. We approached all
176 primary care physicians registered in the Jerusalem
district of Clalit health services (CHS – the largest gov-
ernmentally funded healthcare insurer and provider),
treating approximately 430,000 enrollees.
The questionnaire presented respondents with phrases
assessing physician actual practices regarding patient
PDM appointment, phrases about physician concerns
regarding the topic, and phrases assessing to which
patients physicians should offer PDM appointment and
discussion of the topic (detailed in the results tables).
The respondents were asked to mark either agreement
or disagreement with each of the phrases. We collected
additional information about the served population char-
acteristics and physician experience. The form was pilot
tested, assessed and improved with several senior geriat-
ric and family physicians. Additionally, a forum of family
physicians filled the form and then, in open discussion,
reviewed the questionnaire and proposed revisions until
content and clarity reached saturation.
We contacted all clinics; there were several attempts to
recruit all registered physicians. In order to ensure partici-
pant anonymity, we discarded the list of participating
physicians at the end of the survey period. There was no
participant identification coded otherwise. The CHS ethics
IRB approved the study, allowing data collection and
inclusion only from physicians agreeing to participate.
Using the chi-square test, we compared groups of doctors
who reported having offered PDM appointment to those
who did not. Pilot questionnaires were not included in
physician survey results.
Results
In the Jerusalem district survey (June 2012), there were
176 registered physicians of whom 63 were not available
(vacation, leave etc.). Of the remaining 113 physicians,
33 were not interested in participating; six did not find
the time to answer the telephone questionnaire and 74
physicians participated. Thus, the respondents consti-
tuted 42 % of the original sample (the response rate) and
66 % of those available (the cooperation rate). Young
physicians (under 45) comprised 12 and 23 % were older
than 60. The mean (SD) age of all the respondents was
53 (7), with 26 (7.5) years in the profession and 14 (8)
years working in the clinic they were approached at.
Female physicians constituted 40 % of the participants.
Most of the respondents (90 %) worked in urban
clinics. Almost two thirds of participants (63 %) served
populations that were mostly Jewish (63 %) and 24 %
served populations that were mostly Muslim Arab.
Physicians classified the communities they work at to
be religious (27 %), observant/traditional (63 %) and
secular (9 %).
Most physicians: discussed EOL topics with their
patients, reported knowledge of the legal option to iden-
tify a PDM; did not discuss PDM delegation with their
patients (Table 1). Among physicians who reported hav-
ing discussed with their patients the topic of PDM
appointment, 67 % reported that patients opted to do so.
We found that 70 % of the physicians, who did not dis-
cuss/offer PDM delegation, stated they wanted to do so.
Most physicians reported having received communica-
tion skills training. Participants most often stated that
the professional most appropriate to discuss the topic is
the family physicians (48 %). Other options were non-
medical professionals from community services (25 %),
hospital doctors (12 %) and in-hospital non-medical pro-
fessionals (9 %).
We asked physicians about various impediments to
PDM delegation discussions and grouped these into four
categories: potential medical hazards caused by raising the
topic; potential communication and relationship hazards;
sense of futility; physician uneasiness (Table 2). The most
common agreement was that patients might change their
minds regarding EOL instructions.
The majority of participants (91 %) thought that dis-
cussing PDM designation was relevant when patients
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were suffering from advanced / severe morbidities such
as cancer, heart failure and renal failure. Far less (47 %)
thought it appropriate to discuss this topic with patients
about to undergo surgery / anesthesia. Raising the mat-
ter with all elderly patients was thought appropriate only
among 24 % of the respondents.
Most respondents (84 %) did not agree that PDM
appointment is useless; and a similarly large percentage
agreed (80 %) that difficult situations should only be
dealt with when they occur and not pre-emptively. About
half (57 %) stated they were interested in appointing a
PDM for themselves in case they are incapable of commu-
nication and that they would be willing to act as a PDM
for a family member or a friend.
When we compared physicians who did and did not
discuss PDM delegation (Table 3), we found that those
who did not, more often, reported that such discussions
could hurt their patients and cause dispute. They also
reported not feeling comfortable raising the topic. None
of the physicians working with religiously observant
communities reported suggesting PDM delegation to
their patients. Most physicians reporting PDM discus-
sions were between 45 and 60 years old (84 %). In this
age group 31 % of physician reported PDM discussion
with their patients whereas in younger and older phys-
ician age groups 11 % reported doing so.
Discussion
The most striking results in this study are the discrep-
ancy between physicians’ knowledge of the PDM option
and the limited use and discussion of this option with
patients. Most physicians indicated that they had pa-
tients with significant co-morbidities/disabilities or life
threatening conditions, which enhances the incongruity.
Another striking result was the widespread agreement
with the statement that patients in practice change their
minds regarding EOL instructions.
Many of the respondents stated that they did not feel
they had received the necessary training to discuss dele-
gation of PDM with their patients. All physicians are
medical school graduates and most had participated in
formal training in patient-physicians communication
skills as part of their resident training. The low rate of
PDM delegation discussions is not an error in system
processes; rather, it reflects a situation in which many
medical institutions do not prioritize the issue. Our
results suggest that teaching and training institutions as
well as administrative and regulatory institutions, do not
value the issue to a notable extent that generates train-
ing, skill and action and appropriate service.
In all societies, EOL is an arena in which ethical and
legal schools of thought clash. Yet, we should note that
unlike other EOL instruction facilities, delegation of PDM
is the least controversial, allowing both pro-life idealists as
well as their opposites, alike, to maximize the potential to
fulfil their autonomy, if they have the misfortune to lack
communication capacity. PDM appointment, more than
other options, allows the greatest future flexibility and is
far less stringent than other EOL empowering / instruc-
tion arrangements. Thus, the physicians’ expressed fear of
changes in patient priorities would be best served by PDM
appointment, rather than specific instruction.
Change and improvement in physician initiatives and
promotion of PDM appointment could be sought in
basic medical education. The medical curriculum is
already congested with increasing requirements to add
material and training to the classical core. EOL care,
Table 1 Physician responses regarding proxy decision-maker
(PDM) delegation (n = 74)
Aware of patient option
of PDM delegation
48 (64 %)
In preceding year, had discussions with patients
on topic of death/ severe disease/ significant
disabilities/ dependence on others.
58 (78 %)




Feel they had not received adequate training to
discuss PDM delegation.
38 (51 %)
Feel that the time available in clinic visit is
insufficient for discussion of the topic.
45 (60 %)
Feel close to the patients in clinic. 72 (97 %)
Table 2 Agreement with phrases which might impede
discussion of PDM
Fear of harm to
patient
Discussing PDM has the
potential to depress the patient
39 (53 %)





Discussing PDM could harm
the doctor-patient relationship
23 (31 %)
Delegation of PDM can lead
to familial disputes
37 (50 %)
Sense of futility Patients are not interested in
discussing delegation of PDM
28 (38 %)
Patient do not have the capacity
to appreciate the complexity of
their medical condition and are
not fit for discussing and deciding
on this topic
21 (28 %)
Patients might change their
mind regarding EOL instruction,




I do not feel comfortable to discuss
the topic
21 (28 %)
I feel burdened by the topic 46 (63 %)
Lifshitz et al. Israel Journal of Health Policy Research  (2016) 5:6 Page 3 of 6
including PDM delegation, has to compete with other
topics on resource allocation in the medical schools.
Previous surveys have shown that 19 to 55 % of se-
verely morbid patients are approached to discuss end-
of-life care topics [1, 6, 7]. Interventions to improve the
prevalence of EOL instructions in outpatient clinics
have been shown to increase these from 24 to 38 % [8].
Similar attempts in hospitalized patients increased the
prevalence of EOL instructions from as low as 0 % to
as high as 36 % [9, 10]. Unsuccessful interventions have
also been reported [11].
One of the limiting factors of EOL instructions and des-
ignation of PDM is lack of physician initiative [2, 3]. Some
physicians believe that such discussions can harm patients
[12]. Other physicians are afraid that such discussions
could harm their relationship with their patients [4]. This
contrasts with studies which have shown that shared for-
mation of EOL instructions strengthens patient-doctor
relationships and that patients do wish to discuss these
topics, even if stress and anxiety ensue [1, 3].
The Israeli Law for the Dying Patient is an attempt to
balance between the values of patient’s autonomy and
sanctity of life [13]. The law establishes procedures for
appointing proxy decision-makers and leaving advance
medical directives. Every 5 years, a national registry
reminds, those who have filed advance directives to
check whether they have changed their minds. The
registry serves as a source of information whenever an
incompetent patient is admitted to a hospital and it is un-
known whether there is an advance directive. Testimony
about patient’s wishes by family or friends is also valid.
While the law was enacted a decade ago, physicians still
have poor knowledge of it [14] and implementation has
been slow [15]. Despite legislation aimed toward expansion
of individual autonomy, current policy promotes court-
appointed guardianship for all patients with dementia
rather than eliciting individual preferences when this is still
an option [16]. There is a recognized need for increased
awareness among the public and training health care pro-
viders to conduct timely conversations about preferences
for end-of-life care [14–16]. PDM are people identified by
patients as being the ability to deliberate and communicate
the patients’ autonomy. This should not be confused with
legal representatives charged to be acting guardians of the
patients.
Another driver of change could be quality measures.
EOL care is a very delicate personal, ethical, cultural and
political topic, to say the least [17]. Yet, PDM has the po-
tential to receive wide public acceptance, among various
belief holders. As a quality measure, it would reflect far
more than procedural appointment, and would probably
promote patient-doctor-system coordination, communica-
tion and confidence. However, quality measures might
lead to gaming strategies, draining the topic from its con-
tent and lead to a system aggressively seeking to discuss
the matter only for the sake of appearance and rating.
Participant selection bias restrains the external validity
of our findings and conclusions. The ethical approval we
received allowed us to include information about only
those physicians who agreed to participate in the study.
Therefore, we were not in a position to gather data
about physicians in the Jerusalem district who work in
CHS and cannot truly account to the extent of selection
in that group. Comparing the age and sex composition
of our participants, 44 % of randomly selected physicians
in a national survey of primary care physicians were
female [18] and 45 % of all registered community work-
ing physicians in a 2012 census were female [19]; similar
Table 3 Bivariate analysis: FPs who discussed PDM vs. those who did not
YesN = 18 NoN = 56 p-value
Patients are not interested 5 (28 %) 23 (41 %) 0.4
Cause family dispute 5 (28 %) 32 (57 %) 0.05
Depress the patient 4 (22 %) 35 (62 %) 0.006
Compromise medical status 0 13 (23 %) 0.03
Patients cannot perceive the consequences of their decisions 3 (17 %) 18 (32 %) 0.24
Patients might change their minds 16 (89 %) 53 (95 %) 0.59
I do not feel comfortable to discuss the topic 1 (6 %) 20 (36 %) 0.02
I feel burdened by the topic 12 (66 %) 34 (60 %) 0.7
Harm doctor/patient relationship 3 (16 %) 20 (36 %) 0.16
I do not believe discussions are of any good 1 (6 %) 11 (20 %) 0.33
There is no reason to discuss this issue before anything really happens 0 15 (27 %) 0.02
Should discuss with all elderly patients 5 (28 %) 13 (23 %) 0.76
Should discuss with patients about to undergo surgery 10 (56 %) 25 (46 %) 0.6
Should discuss with patients suffering life-shortening diseases 16 (89 %) 52 (93 %) 0.63
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to our group composition. However, the age distribution
of our participants differs substantially from that of the
aforementioned reports: In the random survey of primary
care physicians approximately 26 % were under 45 and
19 % were older than 60 [18]; in the national physician
census 22 % were under 45 and 11 % were older than 65
[19]. Our participants, in that respect are somewhat differ-
ent: 12 % were younger than 45, and 23 % were older than
60. The basic demographic comparisons do not disclose
any clear bias that might have been introduced in this
current report; however, they certainly suggest that the
generalizability of our findings is not straightforward.
This report should be cautiously interpreted. The
Jerusalem district is unique as the various religious incli-
nations might be more intense due to the association
with the holy city and sacred history. Indeed, physicians
caring for mostly observant communities did not report
PDM delegation discussions. Among physicians and
patients of all religions, tension might be raised between
opposing standards brought by religious and spiritual
influences. Additionally, the study gathered only physi-
cians self-reported actions and thought. There is no sys-
tematic standard to document EOL associated actions
and, additionally, retrieve data regarding the actual
behavior of family physicians in Israel.
Finally, in an era of austerity and financial constraints,
there is growing appreciation of the resource consump-
tion that occurs during the end of life, often with a sense
of significant futility. In many instances, the medical
imperative, when no legal avenues exist for withholding
treatment, is to provide any and all treatment modalities
available, as dictated by the clinical entities the patient
presents with. Opportunities to communicate with
people chosen and empowered by the patient to be the
optimal agents of his will can enable treatment in
accordance with his wishes or guided by his ideals. This
could result in less costly, more humane and palliative
care within a legal framework and provide confident
value when resources are used, knowing that this fulfills
patient preferences, thus adding to their worth, perhaps
decreased moral stress [20].
Conclusions
Family physicians in Israel are not, as of yet, potent facilita-
tors of PDM delegation. It seems that this topic has not
been the focus of the medical establishment’s components,
from medical school, continuing medical education or qual-
ity monitoring. Specific EOL directed teaching, training,
skill maintenance and monitoring could serve patients and
society by promoting autonomy fulfillment and meaningful
care, whether palliative and invasive, passive or active.
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